Chembio Diagnostics Wins Supply Order

Shares of Chembio Diagnostics were up almost 5% Wednesday after the company said it has secured a $5.8 million order from Bio-Manguinhos/Fiocruz to supply components for the production of the company’s DPP HIV 1/2 assay in Brazil and for the subsequent supply to Brazil’s Health Ministry. Chembio’s DPP HIV 1/2 assay detects antibodies to HIV-1 and HIV-2 in oral fluid, blood, serum or plasma samples, and can provide results in 15 minutes.

Chembio also said that its Medford, New York facility received GMC certification from Brazil’s health agency, which allows for direct imports from the facility. Bio-Manguinhos/Fiocruz is a unit of the Oswaldo Cruz Foundation, which is responsible for developing and producing vaccines, diagnostics and biopharmaceuticals, mostly to meet the demands of Brazil’s national public health system.

Leave a Comment